Innate Pharma
IPHA
#8408
Rank
โ‚น13.63 B
Marketcap
โ‚น156.43
Share price
-4.19%
Change (1 day)
-25.04%
Change (1 year)

Market capitalization of Innate Pharma (IPHA)

Market cap: โ‚น13.63 Billion

As of April 2025 Innate Pharma has a market cap of โ‚น13.63 Billion. This makes Innate Pharma the world's 8408th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Innate Pharma from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น13.63 B-9.03%
2024โ‚น14.99 B-21.79%
2023โ‚น19.16 B-22.58%
2022โ‚น24.75 B-16.96%
2021โ‚น29.81 B21.22%
2020โ‚น24.59 B-34.44%
2019โ‚น37.52 B-1.45%
2018โ‚น38.07 B83.09%
2017โ‚น20.79 B-63.22%
2016โ‚น56.54 B6.82%
2015โ‚น52.93 B64.25%
2014โ‚น32.23 B66.66%
2013โ‚น19.33 B224.43%
2012โ‚น5.96 B119.02%
2011โ‚น2.72 B3.94%
2010โ‚น2.61 B-56.53%
2009โ‚น6.02 B151.78%
2008โ‚น2.39 B-33.64%
2007โ‚น3.60 B-43%
2006โ‚น6.32 B

End of Day market cap according to different sources

On Apr 4th, 2025 the market cap of Innate Pharma was reported to be:

โ‚น12.58 Billion
by Nasdaq info icon info icon
โ‚น13.63 Billion
by CompaniesMarketCap info icon info icon
โ‚น13.63 Billion
by Yahoo Finance info icon info icon